Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase

International Journal of Pharmaceutics

Volumn 173, Issue 1-2, 1998, Pages 51-60

  Chang, Chin Ming ^a,c   Bodmeier, Roland ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Cubic phase; Liquid crystalline phase; Monoglycerides; Sustained drug release

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ALCOHOL; CHLORPHENIRAMINE MALEATE; GLYCEROL OLEATE; MACROGOL; MONOACYLGLYCEROL; PROPRANOLOL;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; VISCOSITY;

EID: 0032445939     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00180-X     Document Type: Article

References (19)

1. Bodmeier, R., Herrmann, J., 1997. Waxes. In: Swarbrick, J., Boylan, J.C. (Eds.), Encyclopedia of Pharmaceutical Technology, vol. 16. Marcel Dekker, New York, pp. 335-361.
2. Chang, C.M., Bodmeier, R., 1997a. Effect of dissolution media and additives on the drug release from cubic phase delivery systems. J. Control. Release 46, 215-222.
3. Chang, C.M., Bodmeier, R., 1997b. Binding of drugs to monoglyceride-based drug delivery systems. Int. J. Pharm. 147, 135-142.
4. Chang, C.M., Bodmeier, R., 1997c. Swelling of and drug release from monoglyceride-based drug delivery systems. J. Pharm. Sci. 86 (6), 747-752.
5. Collet, J.H., Atwood, D., Burrows, R., 1990. The release of drugs with low aqueous solubility from liquid crystalline phases. Proc. Int. Symp. Control. Release Bioactive Mater. 17, 283-284.
6. Damani, N.C., 1991. Sustained-release compositions containing monoolein and drugs for treating periodontal disease. European Patent Application EP 429224 A1, date: 910529.
7. Doelker, C., Doelker, E., 1982. Sustained-release compressions: prominent release mechanisms of glyceride matrices. Pharm. Acta Helv. 57, 189-192.
8. Engström, S., 1988. Cubic phases as drug delivery systems. Proc. Int. Symp. Control. Release Bioactive Mater. 15, 157-158.
9. Engström, S., 1990. Drug delivery from cubic and other lipid-water phases. Lipid Technol. 2, 42-45.
10. Engström, S., Lindahl, L., Wallin, R., Engblom, J., 1992. A study of polar lipid drug carrier systems undergoing a thermoreversible lamellar-to-cubic phase transition. Int. J. Pharm. 86 (2-3), 137-145.
11. Ericsson, B., Leander, S., Ohlin, M., 1988. Liquid crystalline phases as delivery systems for drugs. III: In vivo. Proc. Int. Symp. Control. Release Bioactive Mater. 15, 382-383.
12. Geraghty, P.B., Attwood, D., Collett, J.H., Sharma, H., Dandiker, Y., 1997. An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99/ water gels. Biomaterials 18, 63-67.
13. Hyde, S.T., Andersson, S., Ericsson, B., Larsson, K., 1984. A cubic structure consisting of a lipid bilayer forming an infinite periodic minimum surface of the gyroid type in the glycerol monooleate-water system. Z. Kristallogr. 168 (1-4), 213-219.
14. Lee, B.S.P., 1988. Raman spectroscopic studies of the antitumor drugs adriamycin and mitoxantrone, 1,4-dihydroxyanthraquinone, methylamine dehydrogenase in monoolein/water system. Ph.D. dissertation, Ohio State University, Columbus, OH.
15. Leslie, S.B., Puwada, S., Ratna, B.R., Rudolph, A.S., 1996. Encapsulation of hemoglobin in a bicontinuous cubic phase lipid. Biochim. Biophys. Acta 1285, 246-254.
16. Lutton, E.S., 1965. Phase behavior of aqueous systems of monoglycerides. J. Am. Oil Chem. Soc. 42, 1068-1070.
17. Norling, T., Lading, P., Engström, S., Larsson, K., Krog, N., Nissen, S.S., 1992. Formulation of drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J. Clin. Periodontol. 19, 687-692.
18. Rosevear, F.B., 1954. The microscopy of the liquid crystalline neat and middle phases of soaps and synthetic detergents. J. Am. Oil Chem. Soc. 31, 628-639.
19. Wyatt, D.M., Dorschel, D.A., 1992. Cubic-phase delivery system composed of glyceryl monooleate and water for sustained release of water-soluble drugs. Pharm. Technol. 16 (10), 116, 118, 120, 122, 130.